World Health Statistics 2023. Monitoring health for the SDGs, Sustainable Development Goals. Geneva: World Health Organization; 2023. Licence: CC BY‑NC‑SA 3.0 IGO.
Cromwell WC, Otvos JD, Keyes MJ, Pencina MJ, Sullivan L, Vasan RS, Wilson PW, D’Agostino RB. LDL particle number and risk of future cardiovascular disease in the Framingham offspring study – implications for LDL management. J Clin Lipidol. 2007;1(6):583–92. https://doi.org/10.1016/j.jacl.2007.10.001.
Woods SC, Seeley RJ, Rushing PA, D’Alessio D, Tso P. A controlled high-fat diet induces an obese syndrome in rats. J Nutr. 2003;133(4):1081–7. https://doi.org/10.1093/jn/133.4.1081.
Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V, Kauter K, Sernia C, Campbell F, Ward L, Gobe G, Fenning A, Brown L. High-carbohydrate high-fat diet–induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol. 2011;57(1):51–64. https://doi.org/10.1097/FJC.0b013e3181feb90a. Erratum in: J Cardiovasc Pharmacol. 2011 57(5):610. Corrected and republished in: J Cardiovasc Pharmacol. 2011;57(5):611-24.
Calligaris SD, Lecanda M, Solis F, Ezquer M, Gutiérrez J, Brandan E, Leiva A, Sobrevia L, Conget P. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy. Plos One. 2013;8(4):e60931. https://doi.org/10.1371/journal.pone.0060931.
Savastano DM, Covasa M. Adaptation to a high-fat diet leads to hyperphagia and diminished sensitivity to cholecystokinin in rats. J Nutr. 2005;135(8):1953–9. https://doi.org/10.1093/jn/135.8.1953.
Seol W, Choi HS, Moore DD. An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors. Science. 1996;272(5266):1336–9. https://doi.org/10.1126/science.272.5266.1336.
Forman BM, Goode E, Chen J, Oro AE, Bradley DJ, Perlmann T, Noonan DJ, Burka LT, McMorris T, Lamph WW, Evans RM, Weinberger C. Identification of a nuclear receptor that is activated by farnesol metabolites. Cell. 1995;81(5):687–93. https://doi.org/10.1016/0092-8674(95)90530-8.
Makishima M, Okamoto AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B. Identification of a nuclear receptor for bile acids. Science. 1999;284(5418):1362–5. https://doi.org/10.1126/science.284.5418.1362.
Huber RM, Murphy K, Miao B, Link JR, Cunningham MR, Rupar MJ, Gunyuzlu PL, Haws TF, Kassam A, Powell F, Hollis GF, Young PR, Mukherjee R, Burn TC. Generation of multiple farnesoid-X-receptor isoforms through the use of alternative promoters. Gene. 2002;290(1–2):35–43. https://doi.org/10.1016/s0378-1119(02)00557-7.
Wang YD, Chen WD, Wang M, Yu D, Forman BM, Huang W. Farnesoid X receptor antagonizes nuclear factor kappaB in hepatic inflammatory response. Hepatology. 2008;48(5):1632–43. https://doi.org/10.1002/hep.22519.
Bishop-Bailey D, Walsh DT, Warner TD. Expression and activation of the farnesoid X receptor in the vasculature. Proc Natl Acad Sci U S A. 2004;101(10):3668–73. https://doi.org/10.1073/pnas.0400046101.
Pu J, Yuan A, Shan P, Gao E, Wang X, Wang Y, Lau WB, Koch W, Ma XL, He B. Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia/reperfusion injury. Eur Heart J. 2013;34(24):1834–45. https://doi.org/10.1093/eurheartj/ehs011. Epub 2012 Feb 3.
Mencarelli A, Cipriani S, Renga B, D’Amore C, Palladino G, Distrutti E, Baldelli F, Fiorucci S. FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity. Nutr Metab Cardiovasc Dis. 2013;23(2):94–101. https://doi.org/10.1016/j.numecd.2011.06.008.
Ghosh N, Das A, Khanna S. Vitamin E: tocopherols and tocotrienol and their role in health and disease. Essential and toxic trace elements and vitamins in human health. 2019; 283–293. https://doi.org/10.1016/B978-0-12-805378-2.00020-6. Accessed 9 Nov. 2023
Li F, Tan W, Kang Z, Wong CW. Tocotrienol enriched palm oil prevents atherosclerosis through modulating the activities of peroxisome proliferation-activated receptors. Atherosclerosis. 2010;211(1):278–82.
Qureshi AA, Bradlow AB, Salser WA, Brace LD. Novel tocotrienols of rice bran modulate cardiovascular disease risk parameter of hypercholestrolemic humans. J Nutr Biochemistry. 1997;8(5):290–8.
Black TM, Wang P, Maeda N, Coleman RA. Palm tocotrienols protect ApoE +/- mice from diet-induced atheroma formation. J Nutr. 2000;130(10):2420–6. https://doi.org/10.1093/jn/130.10.2420.
Razak AA, Omar E, Muid S, Nawawi H. Low dose palm tocotrienol-rich fraction reduces aortic tissue endothelial activation in severely atherosclerotic rabbits. Pertanika J Sci Technol. 2017;25(S8):63–72.
Shibata A, Kobayashi T, Asai A, Eitsuka T, Oikawa S, Miyazawa T, Nakagawa K. High purity tocotrienols attenuate atherosclerotic lesion formation in apoE-KO mice. J Nutr Biochem. 2017;48:44–50. https://doi.org/10.1016/j.jnutbio.2017.06.009.
Ali SF, Woodman OL. Tocotrienol rich palm oil extract is more effective than pure tocotrienols at improving endothelium-dependent relaxation in the presence of oxidative stress. Oxid Med Cell Longev. 2015;2015:150829. https://doi.org/10.1155/2015/150829.
Abdul Khalid NA, Jubri Z. The protective effect of palm tocotrienol-rich fraction against H2O2– induced oxidative stress in neonatal rat cardiomyocytes. PeerJ Preprints. 2017;5:e3333v1. https://doi.org/10.7287/peerj.preprints.3333v1.
AbdMuid S, Froemming GAF, Ali AM, Abdul Rahman T, Hamid Z, Nawawi H. Effects of palm oil derived tocotrienol rich fraction vitamin E isomers on biomarkers of early atherogenesis in stimulated human umbilical vein endothelial cells. Malaysia App Biol. 2022;51(4):145.
Das S, Lekli I, Das M, Szabo G, Varadi J, Juhasz B, Bak I, Nesaretam K, Tosaki A, Powell SR, Das DK. Cardiprotection with palm oil tocotrienol: comparison of different isomers. Am J Physio Heart Circ Physiol. 2008;294(2):H970–8.
Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, Gauthier C, Jacques PÉ, Li S, Xia J. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388–96. https://doi.org/10.1093/nar/gkab382.
Feriani A, Bizzarri M, Tir M, Aldawood N, Alobaid H, Allagui MS, Dahmash W, Tlili N, Mnafgui K, Alwasel S, Harrath AH. High-fat diet-induced aggravation of cardiovascular impairment in permethrin-treated Wistar rats. Ecotoxicol Environ Saf. 2021;222:112461. https://doi.org/10.1016/j.ecoenv.2021.112461.
Nagarajan V, Gopalan V, Kaneko M, Angeli V, Gluckman P, Richards AM, Kuchel PW, Velan SS. Cardiac function and lipid distribution in rats fed a high-fat diet: in vivo magnetic resonance imaging and spectroscopy. Am J Physiol Heart Circ Physiol. 2013;304(11):H1495–504. https://doi.org/10.1152/ajpheart.00478.2012.
Avtanski D, Pavlov VA, Tracey KJ, Poretsky L. Characterization of inflammation and insulin resistance in high-fat diet-induced male C57BL/6J mouse model of obesity. Animal Model Exp Med. 2019;2(4):252–8. https://doi.org/10.1002/ame2.12084.
Fraulob JC, Ogg-Diamantino R, Fernandes-Santos C, Aguila MB, Mandarim-de-Lacerda CA. A mouse model of metabolic syndrome: insulin resistance, fatty liver and non-alcoholic fatty pancreas disease (NAFPD) in C57BL/6 mice fed a high fat diet. J Clin Biochem Nutr. 2010;46(3):212–23. https://doi.org/10.3164/jcbn.09-83.
Wang CY, Liao JK. A mouse model of diet-induced obesity and insulin resistance. Methods Mol Biol. 2012;821:421–33. https://doi.org/10.1007/978-1-61779-430-8_27.
Kim KE, Jung Y, Min S, Nam M, Heo RW, Jeon BT, Song DH, Yi CO, Jeong EA, Kim H, Kim J, Jeong SY, Kwak W, do Ryu H, Horvath TL, Roh GS, Hwang GS. Caloric restriction of db/db mice reverts hepatic steatosis and body weight with divergent hepatic metabolism. Sci Rep. 2016;6:30111. https://doi.org/10.1038/srep30111.
Mesri Alamdari N, Irandoost P, Roshanravan N, Vafa M, Asghari Jafarabadi M, Alipour S, Roshangar L, Alivand M, Farsi F, Shidfar F. Effects of royal jelly and tocotrienol rich fraction in obesity treatment of calorie-restricted obese rats: a focus on white fat browning properties and thermogenic capacity. Nutr Metab (Lond). 2020;17:42. https://doi.org/10.1186/s12986-020-00458-8.
Irandoost P, Mesri Alamdari N, Saidpour A, Shidfar F, Roshanravan N, Asghari Jafarabadi M, Farsi F, Asghari Hanjani N, Vafa M. The effects of royal jelly and tocotrienol-rich fraction on impaired glycemic control and inflammation through irisin in obese rats. J Food Biochem. 2020;44(12):e13493. https://doi.org/10.1111/jfbc.13493.
Allen L, Ramalingam L, Menikdiwela K, Scoggin S, Shen CL, Tomison MD, Kaur G, Dufour JM, Chung E, Kalupahana NS, Moustaid-Moussa N. Effects of delta-tocotrienol on obesity-related adipocyte hypertrophy, inflammation and hepatic steatosis in high-fat-fed mice. J Nutr Biochem. 2017;48:128–37. https://doi.org/10.1016/j.jnutbio.2017.07.003.
Budin SB, Othman F, Louis SR, Bakar MA, Das S, Mohamed J. The effects of palm oil tocotrienol-rich fraction supplementation on biochemical parameters, oxidative stress and the vascular wall of streptozotocin-induced diabetic rats. Clinics (Sao Paulo). 2009;64(3):235–44. https://doi.org/10.1590/s1807-59322009000300015.
Matough FA, Budin SB, Hamid ZA, Abdul-Rahman M, Al-Wahaibi N, Mohammed J. Tocotrienol-rich fraction from palm oil prevents oxidative damage in diabetic rats. Sultan Qaboos Univ Med J. 2014;14(1):e95–103. https://doi.org/10.12816/0003342.
Khor SC, Wan Ngah WZ, Mohd Yusof YA, Abdul Karim N, Makpol S. Tocotrienol-rich fraction ameliorates antioxidant defense mechanisms and improves replicative senescence-associated oxidative stress in human myoblasts. Oxid Med Cell Longev. 2017;2017:3868305. https://doi.org/10.1155/2017/3868305.
Karnati S, Lüers G, Pfreimer S, Baumgart-Vogt E. Mammalian SOD2 is exclusively located in mitochondria and not present in peroxisomes. Histochem Cell Biol. 2013;140(2):105–17. https://doi.org/10.1007/s00418-013-1099-4.
Peh HY, Ho WE, Cheng C, Chan TK, Seow ANG, Lim AYH, Fong CW, Seng KY, Ong CN, Wong WSF. Vitamin E isoform gamma tocotrienol downregulates house dust mite-induced asthma. J Immunology. 2015;195(2):437–44.0.
Durani LW, Jaafar F, Tan JK, Tajul Arifin K, Mohd Yusof YA, Wan Ngah WZ, Makpol S. Targeting genes in insulin-associated signalling pathway, DNA damage, cell proliferation and cell differentiation pathways by tocotrienol-rich fraction in preventing cellular senescence of human diploid fibroblasts. Clin Ter. 2015;166(6):e365–73. https://doi.org/10.7417/T.2015.1902.
Claudel T, Staels B, Kuipers F. The farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. Arterioscler Thromb Vasc Biol. 2005;25(10):2020–30. https://doi.org/10.1161/01.ATV.0000178994.21828.a7.
Khurana S, Raufman JP, Pallone TL. Bile acids regulate cardiovascular function. Clin Transl Sci. 2011;4(3):210–8. https://doi.org/10.1111/j.1752-8062.2011.00272.x.
Qi YC, Duan GZ, Mao W, Liu Q, Zhang YL, Li PF. Taurochenodeoxycholic acid mediates cAMP-PKA-CREB signaling pathway. Chin J Nat Med. 2020;18(12):898–906. https://doi.org/10.1016/S1875-5364(20)60033-4.
Talebian R, Hashem O, Gruber R. Taurocholic acid lowers the inflammatory response of gingival fibroblasts, epithelial cells, and macrophages. J Oral Sci. 2020;62(3):335–9. https://doi.org/10.2334/josnusd.19-0342.
Add Comment